View in EDS HTML Full Text PDF Full Text

PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.

Saved in:
Bibliographic Details
Title: PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
Authors: Luszczak S; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Kumar C; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Sathyadevan VK; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Simpson BS; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Gately KA; Trinity Translational Medicine Institute, St. James's Hospital Dublin, Dublin 8, Dublin, Ireland., Whitaker HC; Molecular Diagnostics and Therapeutics Group, University College London, London, UK., Heavey S; Molecular Diagnostics and Therapeutics Group, University College London, London, UK. s.heavey@ucl.ac.uk.
Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2020 Jan 31; Vol. 5 (1), pp. 7. Date of Electronic Publication: 2020 Jan 31.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32296034
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Luszczak+S%22">Luszczak S</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Kumar+C%22">Kumar C</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Sathyadevan+VK%22">Sathyadevan VK</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Simpson+BS%22">Simpson BS</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Gately+KA%22">Gately KA</searchLink>; Trinity Translational Medicine Institute, St. James's Hospital Dublin, Dublin 8, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Whitaker+HC%22">Whitaker HC</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Heavey+S%22">Heavey S</searchLink>; Molecular Diagnostics and Therapeutics Group, University College London, London, UK. s.heavey@ucl.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101676423%22">Signal transduction and targeted therapy</searchLink> [Signal Transduct Target Ther] 2020 Jan 31; Vol. 5 (1), pp. 7. <i>Date of Electronic Publication: </i>2020 Jan 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101676423 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-3635 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220593635%22">20593635 </searchLink><i>NLM ISO Abbreviation: </i>Signal Transduct Target Ther
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32296034
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41392-020-0109-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7
    Titles:
      – TitleFull: PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Luszczak S
      – PersonEntity:
          Name:
            NameFull: Kumar C
      – PersonEntity:
          Name:
            NameFull: Sathyadevan VK
      – PersonEntity:
          Name:
            NameFull: Simpson BS
      – PersonEntity:
          Name:
            NameFull: Gately KA
      – PersonEntity:
          Name:
            NameFull: Whitaker HC
      – PersonEntity:
          Name:
            NameFull: Heavey S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 01
              Text: 2020 Jan 31
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2059-3635
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Signal transduction and targeted therapy
              Type: main
ResultId 1